Susquehanna International Group
ENZ

Susquehanna International Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Susquehanna International Group’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60,041
Closed -$22.2K – 14038
2025
Q1 		$22.2K Buy
60,041
+26,206
+77% +$14.5K ﹤0.01% 12087
2024
Q4 		$24.2K Buy
+33,835
New +$35.1K ﹤0.01% 11887
2024
Q2 		– Sell
-24,270
Closed -$30.8K – 13439
2024
Q1 		$30.8K Buy
+24,270
New +$32.1K ﹤0.01% 11710
2023
Q2 		– Sell
-18,643
Closed -$45.3K – 13352
2023
Q1 		$45.3K Sell
18,643
-9,585
-34% -$14.3K ﹤0.01% 11736
2022
Q4 		$40.4K Buy
+28,228
New +$55K ﹤0.01% 11508
2022
Q3 		– Sell
-21,943
Closed -$53K – 14296
2022
Q2 		$45K Buy
+21,943
New +$54.3K ﹤0.01% 12040
2022
Q1 		– Sell
-39,619
Closed -$127K – 14162
2021
Q4 		$127K Sell
39,619
-54,896
-58% -$187K ﹤0.01% 11970
2021
Q3 		$335K Buy
94,515
+50,688
+116% +$169K ﹤0.01% 10338
2021
Q2 		$139K Sell
43,827
-23,143
-35% -$72.8K ﹤0.01% 11899
2021
Q1 		$230K Buy
66,970
+21,678
+48% +$67.4K ﹤0.01% 11146
2020
Q4 		$114K Buy
+45,292
New +$98.6K ﹤0.01% 10435
2020
Q3 		– Sell
-24,177
Closed -$57.4K – 11268
2020
Q2 		$54K Sell
24,177
-19,919
-45% -$51.2K ﹤0.01% 9729
2020
Q1 		$112K Buy
44,096
+9,414
+27% +$23.1K ﹤0.01% 9244
2019
Q4 		$91K Buy
34,682
+3,557
+11% +$10.6K ﹤0.01% 9178
2019
Q3 		$112K Sell
31,125
-11,913
-28% -$42.2K ﹤0.01% 9500
2019
Q2 		$145K Buy
+43,038
New +$152K ﹤0.01% 9398
2019
Q1 		– Sell
-20,084
Closed -$56K – 10019
2018
Q4 		$56K Sell
20,084
-6,993
-26% -$22.9K ﹤0.01% 8443
2018
Q3 		$112K Buy
27,077
+2,408
+10% +$10.9K ﹤0.01% 8560
2018
Q2 		$128K Buy
+24,669
New +$150K ﹤0.01% 8943
2017
Q4 		– Sell
-56,017
Closed -$535K – 10034
2017
Q3 		$586K Sell
56,017
-10,435
-16% -$116K ﹤0.01% 6251
2017
Q2 		$734K Buy
+66,452
New +$619K ﹤0.01% 5915
2017
Q1 		– Sell
-59,969
Closed -$422K – 10163
2016
Q4 		$416K Buy
+59,969
New +$383K ﹤0.01% 7361
2016
Q2 		– Sell
-90,250
Closed -$501K – 9470
2016
Q1 		$411K Buy
90,250
+37,908
+72% +$169K ﹤0.01% 6740
2015
Q4 		$236K Buy
52,342
+33,308
+175% +$141K ﹤0.01% 8147
2015
Q3 		$60K Sell
19,034
-68,212
-78% -$207K ﹤0.01% 9326
2015
Q2 		$264K Buy
87,246
+69,783
+400% +$196K ﹤0.01% 8776
2015
Q1 		$52K Buy
17,463
+7,012
+67% +$23K ﹤0.01% 9143
2014
Q4 		$46K Sell
10,451
-3,278
-24% -$15.6K ﹤0.01% 9376
2014
Q3 		$71K Sell
13,729
-20,478
-60% -$109K ﹤0.01% 9153
2014
Q2 		$179K Sell
34,207
-39,300
-53% -$170K ﹤0.01% 9154
2014
Q1 		$306K Buy
+73,507
New +$252K ﹤0.01% 7563
2013
Q3 		– Sell
-35,746
Closed -$84.8K – 8851
2013
Q2 		$74K Buy
+35,746
New +$78.9K ﹤0.01% 7881

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Susquehanna International Group's ENZ Position: Q2 2025 in Review

Susquehanna International Group sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 60,041 shares — an estimated $22.2K sold.

Susquehanna International Group first reported a position in ENZ in Q2 2013 and held it in 32 quarters. The position peaked at $734K in Q2 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Susquehanna International Group reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 60,041 Enzo Biochem, Inc. shares in Q2 2025, an estimated $22.2K.
  • Susquehanna International Group first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 32 quarters.
  • Susquehanna International Group's Enzo Biochem, Inc. position peaked at $734K in Q2 2017.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.